Literature DB >> 2642776

Imaging evaluation of the candidate for percutaneous lumbar discectomy.

J H Mink1.   

Abstract

Percutaneous lumbar discectomy has been advocated as an alternate means of treating lumbar disc disease. A disc treatable by this method must not be free in the spinal canal and cannot be above or below the disc space. Magnetic resonance imaging, computed tomography, and discography all can be valuable in selecting patients for percutaneous lumbar discectomy.

Entities:  

Mesh：

Year:  1989        PMID： 2642776

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


  6 in total

Review 1.  Clinical efficacy of imaging modalities in the diagnosis of low-back pain disorders.

Authors:  N Boos; P H Lander
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

2.  Cost-effectiveness of percutaneous automated lumbar nucleotomy. Comparison with traditional macro-procedure discectomy.

Authors:  R Dullerud; H Lie; B Magnæs
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  Comparison of MR imaging findings between extraligamentous and subligamentous disk herniations in the lumbar spine.

Authors:  K-J Oh; J W Lee; B L Yun; S T Kwon; K-W Park; J S Yeom; H S Kang
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-06       Impact factor: 3.825

4.  Effect of Nd:YAG laser on experimental disc degeneration. Part I. Biochemical and radiographical analysis.

Authors:  M Turgut; B Açikgöz; K Kilinç; O E Ozcan; A Erbengi
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Automated percutaneous lumbar discectomy.

Authors:  C A Helms; G Onik; G W Davis
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

6.  Percutaneous nucleotomy in the treatment of lumbar disc herniation results after a mean follow-up of 2 years.

Authors:  E Kotilainen; S Valtonen
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.